Health Innovation Oxford and Thames Valley (HIOTV) joined the world’s respiratory experts at ERS Congress 2025 in Amsterdam (27 September–1 October). This year’s congress focused on respiratory health around the globe, with thousands of respiratory professionals broadening their knowledge and expertise by sharing the latest advances in global lung health.
“Conversations at ERS remind us what matters most: better outcomes for patients. By focusing on evidence and translating innovation into practice, we can advance care and improve lives.” James Rose, Director of Strategic and Industry Partnerships, HIOTV.
At the congress, we presented two posters on innovations designed to improve respiratory care in the NHS: a digital app for severe asthma management and an AI-enabled device for rapid chronic obstructive pulmonary disease (COPD) diagnosis. James Rose and Lauren Hudson (pictured), Evaluation and Adoption Project Manager, shared our work with an international audience of clinicians, researchers and innovators.
James said “Together, these studies show how early evidence can reveal both promise and practical barriers. This is where our role matters: linking innovators, clinicians and patients to shape solutions that work in the NHS.”
New approaches to asthma management and COPD diagnosis
Helping people manage severe asthma with digital tools
We evaluated myAsthma Biologic, a digital app developed by my mhealth, which supports people with severe asthma to understand and manage their condition and record key information. The app is also able to automate upload of clinical data to the National Severe Asthma Registry.
Patients found the app easy to use, with features such as peak flow diary and medication tracking helping them to self manage their asthma. Nationally, 69% of patients completing a my mhealth feedback survey said the app made them feel more confident in managing their asthma.
Clinicians valued the app as an aid to self-management and recognised its potential to reduce administrative burden. However, they noted that structured onboarding, staff training and clear review processes will be needed before full integration into clinical pathways.
Access the full asthma poster here
A new way to speed up COPD diagnosis
N-Tidal Diagnose 1® is a point-of-care diagnostic device, created by TidalSense. It helps GPs diagnose COPD in minutes. The test takes just 75 seconds of relaxed breathing and performs real-time geometric analysis of carbon dioxide breath waveforms to provide highly sensitive quantification of lung function. A result is available in five minutes and requires only minimal training for staff.
We carried out a feasibility study across five NHS trusts, speaking with clinicians and commissioners to explore how the device could fit into the current diagnostic pathway. Stakeholders saw real potential for earlier diagnosis in primary care, reduced pressure on secondary care spirometry services, and better outcomes for patients.
Access the full COPD poster here
Are you developing a health innovation? We help turn early evidence into NHS adoption.